// App-Quantinova.ai

: Genomic analysis from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in patients with MIBC undergoing cystectomy.

Researchers

Presenter

  • Shilpa Gupta

Principal Investigators

  • Vladimir Makarov

  • Guru P. Sonpavde

  • Ewan Gibb

  • Sumati Gupta

  • Benjamin L. Maughan

  • Neeraj Agarwal

  • Matthew Mossanen

  • Bharat Thyagarajan

  • C. Marcela Diaz-Montero

  • Prerana Parthasarathy Bangalore

  • Badrinath R. Konety

Medical Centers

  • Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

  • University of Minnesota, Minneapolis, MN

  • Brigham and Women's Hospital, Brookline, MA

  • Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT

  • Allina Health Cancer Institute, Minneapolis, MN

  • AdventHealth Cancer Institute, Orlando, FL

  • Cleveland Clinic Lerner Research Institute, Cleveland, OH

Locations

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bladder Cancer

Biomarkers

  • Solute Carrier Family 25 Member 16

Drug/Treatment

  • Gemcitabine

  • Cisplatin

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • NCT03294304

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved